Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Join global experts at the 2025 International SPECTRALIS Symposium in Heidelberg, exploring innovations in ophthalmology and ...

Villahoz, MD, PhD, talked about 12-month results of vision-related quality of life in myopic children using combination ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment ...

New research links diffuse-trickling patterns in fundus autofluorescence to increased ellipsoidal zone loss, highlighting ...

Belite Bio recently announced the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the ...

At ARVO 2025, in Salt Lake City, Utah, Peng Shang, PhD, talked about her presentation on how the Y402H polymorphism of ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that ...

A recent study reveals a significant rise in childhood astigmatism linked to the COVID-19 pandemic, independent of myopia.

Viridian Therapeutics reveals promising long-term results for veligrotug in treating thyroid eye disease, highlighting its ...